(Q38381729)

2 September 2017

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting (English)

1 reference

2 September 2017

9

1 reference

2 September 2017

35

Elisabeth Paietta

1 reference

2 September 2017

41

Jo-Anne Vergilio

1 reference

2 September 2017

Jie He

1

1 reference

2 September 2017

Omar Abdel-Wahab

2

1 reference

2 September 2017

Michelle K Nahas

3

1 reference

2 September 2017

Kai Wang

4

1 reference

2 September 2017

Raajit K Rampal

5

1 reference

2 September 2017

Andrew M Intlekofer

6

1 reference

2 September 2017

Jay Patel

7

1 reference

2 September 2017

Andrei Krivstov

8

1 reference

2 September 2017

Lauren E Young

10

1 reference

2 September 2017

Shan Zhong

11

1 reference

2 September 2017

Mark Bailey

12

1 reference

2 September 2017

Jared R White

13

1 reference

2 September 2017

Steven Roels

14

1 reference

2 September 2017

Jason Deffenbaugh

15

1 reference

2 September 2017

Alex Fichtenholtz

16

1 reference

2 September 2017

Timothy Brennan

17

1 reference

2 September 2017

Mark Rosenzweig

18

1 reference

2 September 2017

Kimberly Pelak

19

1 reference

2 September 2017

Kristina M Knapp

20

1 reference

2 September 2017

Kristina W Brennan

21

1 reference

2 September 2017

Amy L Donahue

22

1 reference

2 September 2017

Geneva Young

23

1 reference

2 September 2017

Lazaro Garcia

24

1 reference

2 September 2017

Selmira T Beckstrom

25

1 reference

2 September 2017

Mandy Zhao

26

1 reference

2 September 2017

Emily White

27

1 reference

2 September 2017

Vera Banning

28

1 reference

2 September 2017

Jamie Buell

29

1 reference

2 September 2017

Kiel Iwanik

30

1 reference

2 September 2017

Jeffrey S Ross

31

1 reference

2 September 2017

Deborah Morosini

32

1 reference

2 September 2017

Anas Younes

33

1 reference

2 September 2017

Alan M Hanash

34

1 reference

2 September 2017

Kathryn Roberts

36

1 reference

2 September 2017

Charles Mullighan

37

1 reference

2 September 2017

Ahmet Dogan

38

1 reference

2 September 2017

Scott A Armstrong

39

1 reference

2 September 2017

Tariq Mughal

40

1 reference

2 September 2017

Elaine Labrecque

42

1 reference

2 September 2017

Rachel Erlich

43

1 reference

2 September 2017

Christine Vietz

44

1 reference

2 September 2017

Roman Yelensky

45

1 reference

2 September 2017

Philip J Stephens

46

1 reference

2 September 2017

Vincent A Miller

47

1 reference

2 September 2017

Marcel R M van den Brink

48

1 reference

2 September 2017

Geoff A Otto

49

1 reference

2 September 2017

Doron Lipson

50

1 reference

2 September 2017

Ross L Levine

51

1 reference

2 September 2017

language of work or name

English

0 references

publication date

10 March 2016

1 reference

2 September 2017

1 reference

2 September 2017

127

1 reference

2 September 2017

3004-3014

1 reference

2 September 2017

24

1 reference

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia

2 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

The origin and evolution of mutations in acute myeloid leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Clinical effect of point mutations in myelodysplastic syndromes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

BRAF mutations in hairy-cell leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

The IgH 3' regulatory region and its implication in lymphomagenesis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Patterns of somatic mutation in human cancer genomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

The consensus coding sequences of human breast and colorectal cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

6 September 2017

Oncogenes in melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

FLT3 mutations in childhood acute lymphoblastic leukemia

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968346

Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas

31 August 2018

1 reference

12 December 2020

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

12 December 2020

FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse

1 reference

12 December 2020

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11

1 reference

12 December 2020

10.1182/BLOOD-2015-08-664649

Identifiers

DOI

1 reference

2 September 2017

1 reference

2 September 2017

1 reference